Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Seegene, Eidia collaborate on MDx tests
August 2013
SHARING OPTIONS:

GAITHERSBURG, Md.Seegene Inc. has established a collaboration agreement with Eidia, the in-vitro diagnostics subsidiary arm of Eisai Co. Ltd., under which Eidia will be granted access to Seegene's portfolio of TOCE technology-based multiplexed molecular diagnostic tests for the Japanese diagnostic test market. Per the agreement, Seegene will supply multiple TOCE technology-based multiplexed molecular diagnostic tests, which Eidia will exclusively market and distribute in Japan. Eidia will be responsible for securing regulatory clearance from the Japanese Pharmaceutical and Medical Device Agency.  
 
"Our partnership with Eidia opens a significant sales channel for our novel diagnostic tests in Japan. We look forward to working with Eidia to improve patient healthcare with highly sensitive and specific multiplexed MDx tests," said Dr. Jong-Yoon Chun, founder, chief technology officer and CEO of Seegene.  
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.